18 December 1998
The Incidence of Malignancy in Heart Transplant Recipients
M Garlicki, K Wierzbicki, P Przybylowski, D Drop, M Biernat, P Rudzinski, B Olszewska, A DziatkowiakAnn Transplant 1998; 3(4): 41-47 :: ID: 497430
Abstract
Objectives and methods: 219 heart transplant recipients with survival over 3 months were retro- and prospectively analysed for the incidence of primary neoplasms. Patients received immunosuppressive drugs (cyclosporine A, azathioprine,steroids) with a 4-5 days induction course of Rabbit Anti-Thymocyte Immunoglobulin (RATG) or monoclonal antibodies induction /OKT3/ in some cases. Anti-rejection treatment consisted of pulse doses of methyloprednisolon or RATG. Results: 9 cases of malignancy (4,1%) with one case of pre-malignant liver condition (dysplasia gigantocellulare, 0.45%) were found (8M; IF; age: 45-67 y.o., x 57.7). Symptoms of neoplasms occurred 7-79 months (x 31,4) postoperatively. Skin carcinomas: planoepitheliale, spinocellulare, soft tissue neoplasms / mesenchymal sarcoma, larynx Ca planoepitheliale, lung: adenocarcinoma and Ca microcellulare, kidney Ca clarocellulare and post transplant non-Hodgkin lymphoma were diagnosed. Chemo- and radiotherapy, surgery and reduction of immunosuppression did not change the outcome of malignancy in 6 pts.; (regression- I pt was., remission- 2 pts). Patients died 7-86 months after Htx (x 41), 4-25 mos. (x 12.5) after suffering from first symptoms and 0-10 months (x 4,9) after pathology-based diagnosis of neoplasm. Conclusions:Heart transplant recipientshave an increased riskof carcinogenesis.The incidence of malignancies in the studied group is similar or even lower than in other reports.
Keywords: Heart Transplantation, Immunosuppression, Malignancy
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860